rs6173

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000515.5(GH1):​c.-4T>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0417 in 1,606,548 control chromosomes in the GnomAD database, including 1,831 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 335 hom., cov: 32)
Exomes 𝑓: 0.040 ( 1496 hom. )

Consequence

GH1
NM_000515.5 5_prime_UTR

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.0460

Publications

9 publications found
Variant links:
Genes affected
GH1 (HGNC:4261): (growth hormone 1) The protein encoded by this gene is a member of the somatotropin/prolactin family of hormones which play an important role in growth control. The gene, along with four other related genes, is located at the growth hormone locus on chromosome 17 where they are interspersed in the same transcriptional orientation; an arrangement which is thought to have evolved by a series of gene duplications. The five genes share a remarkably high degree of sequence identity. Alternative splicing generates additional isoforms of each of the five growth hormones, leading to further diversity and potential for specialization. This particular family member is expressed in the pituitary but not in placental tissue as is the case for the other four genes in the growth hormone locus. Mutations in or deletions of the gene lead to growth hormone deficiency and short stature. [provided by RefSeq, Jul 2008]
GH1 Gene-Disease associations (from GenCC):
  • isolated growth hormone deficiency type IA
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics
  • isolated growth hormone deficiency type II
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • isolated growth hormone deficiency type IB
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • short stature due to growth hormone qualitative anomaly
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 17-63918780-A-C is Benign according to our data. Variant chr17-63918780-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 324460.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.1 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000515.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GH1
NM_000515.5
MANE Select
c.-4T>G
5_prime_UTR
Exon 1 of 5NP_000506.2
GH1
NM_022559.4
c.-4T>G
5_prime_UTR
Exon 1 of 5NP_072053.1B1A4G7
GH1
NM_022560.4
c.-4T>G
5_prime_UTR
Exon 1 of 4NP_072054.1P01241-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GH1
ENST00000323322.10
TSL:1 MANE Select
c.-4T>G
5_prime_UTR
Exon 1 of 5ENSP00000312673.5P01241-1
GH1
ENST00000458650.6
TSL:1
c.-4T>G
5_prime_UTR
Exon 1 of 5ENSP00000408486.2P01241-2
ENSG00000285947
ENST00000647774.1
c.287-274T>G
intron
N/AENSP00000497443.1A0A3B3ISS9

Frequencies

GnomAD3 genomes
AF:
0.0548
AC:
8328
AN:
152082
Hom.:
335
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.103
Gnomad AMI
AF:
0.00548
Gnomad AMR
AF:
0.0352
Gnomad ASJ
AF:
0.0254
Gnomad EAS
AF:
0.00905
Gnomad SAS
AF:
0.0227
Gnomad FIN
AF:
0.0274
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0427
Gnomad OTH
AF:
0.0383
GnomAD2 exomes
AF:
0.0360
AC:
8968
AN:
249454
AF XY:
0.0350
show subpopulations
Gnomad AFR exome
AF:
0.0846
Gnomad AMR exome
AF:
0.0268
Gnomad ASJ exome
AF:
0.0188
Gnomad EAS exome
AF:
0.0113
Gnomad FIN exome
AF:
0.0308
Gnomad NFE exome
AF:
0.0418
Gnomad OTH exome
AF:
0.0342
GnomAD4 exome
AF:
0.0403
AC:
58640
AN:
1454348
Hom.:
1496
Cov.:
35
AF XY:
0.0394
AC XY:
28508
AN XY:
723706
show subpopulations
African (AFR)
AF:
0.0887
AC:
2851
AN:
32124
American (AMR)
AF:
0.0269
AC:
1197
AN:
44570
Ashkenazi Jewish (ASJ)
AF:
0.0224
AC:
585
AN:
26066
East Asian (EAS)
AF:
0.00831
AC:
330
AN:
39690
South Asian (SAS)
AF:
0.0244
AC:
2102
AN:
86134
European-Finnish (FIN)
AF:
0.0304
AC:
1623
AN:
53420
Middle Eastern (MID)
AF:
0.0398
AC:
228
AN:
5726
European-Non Finnish (NFE)
AF:
0.0427
AC:
47294
AN:
1106534
Other (OTH)
AF:
0.0404
AC:
2430
AN:
60084
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.408
Heterozygous variant carriers
0
2377
4755
7132
9510
11887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1758
3516
5274
7032
8790
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0548
AC:
8338
AN:
152200
Hom.:
335
Cov.:
32
AF XY:
0.0528
AC XY:
3932
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.103
AC:
4265
AN:
41486
American (AMR)
AF:
0.0352
AC:
538
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.0254
AC:
88
AN:
3470
East Asian (EAS)
AF:
0.00926
AC:
48
AN:
5182
South Asian (SAS)
AF:
0.0230
AC:
111
AN:
4832
European-Finnish (FIN)
AF:
0.0274
AC:
291
AN:
10618
Middle Eastern (MID)
AF:
0.0272
AC:
8
AN:
294
European-Non Finnish (NFE)
AF:
0.0427
AC:
2904
AN:
67994
Other (OTH)
AF:
0.0379
AC:
80
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.490
Heterozygous variant carriers
0
377
755
1132
1510
1887
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
88
176
264
352
440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0308
Hom.:
35
Bravo
AF:
0.0581

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
2
not provided (2)
-
-
1
Decreased response to growth hormone stimulation test (1)
-
-
1
GH1-related disorder (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
9.2
DANN
Benign
0.63
PhyloP100
0.046
PromoterAI
-0.0080
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6173; hg19: chr17-61996140; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.